Iradimed (IRMD) Property, Plant & Equipment (Net) Growth (3y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PP&E (Net) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 10.07% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 8.57% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 9.71% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 17.92% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 3.47% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 13.19% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 9.97% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 9.80% |
| 10 | Iradimed | 1.17 Bn | 1.11 Bn | 16.81 Mn | 40.99% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 40.99% |
| Dec 31, 2025 | 115.02% |
| Sep 30, 2025 | 118.13% |
| Jun 30, 2025 | 117.30% |
| Mar 31, 2025 | 111.64% |
| Dec 31, 2024 | 101.03% |
| Sep 30, 2024 | 88.59% |
| Jun 30, 2024 | 71.06% |
| Mar 31, 2024 | 64.43% |
| Dec 31, 2023 | 63.63% |
| Sep 30, 2023 | 60.14% |
| Jun 30, 2023 | 57.62% |
| Mar 31, 2023 | 60.26% |
| Dec 31, 2022 | 5.33% |
| Sep 30, 2022 | 5.13% |
| Jun 30, 2022 | 6.90% |
| Mar 31, 2022 | 4.17% |
| Dec 31, 2021 | 3.44% |
| Sep 30, 2021 | 3.94% |
| Jun 30, 2021 | 3.47% |
| Mar 31, 2021 | 3.63% |
| Dec 31, 2020 | 4.30% |
| Sep 30, 2020 | 5.30% |
| Jun 30, 2020 | 9.22% |
| Mar 31, 2020 | 8.74% |
| Dec 31, 2019 | 12.15% |
| Sep 30, 2019 | 15.40% |
| Jun 30, 2019 | 14.49% |
| Mar 31, 2019 | 21.85% |
| Dec 31, 2018 | 27.33% |
| Sep 30, 2018 | 30.20% |
| Jun 30, 2018 | 31.62% |
| Mar 31, 2018 | 34.04% |
| Dec 31, 2017 | 32.97% |
| Sep 30, 2017 | 34.89% |
| Jun 30, 2017 | 49.59% |
| Dec 31, 2016 | 64.46% |